↓ Skip to main content

Live Vaccination Tactics: Possible Approaches for Controlling Visceral Leishmaniasis

Overview of attention for article published in Frontiers in immunology, March 2014
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
51 Dimensions

Readers on

mendeley
93 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Live Vaccination Tactics: Possible Approaches for Controlling Visceral Leishmaniasis
Published in
Frontiers in immunology, March 2014
DOI 10.3389/fimmu.2014.00134
Pubmed ID
Authors

Noushin Saljoughian, Tahareh Taheri, Sima Rafati

Abstract

Vaccination with durable immunity is the main goal and fundamental to control leishmaniasis. To stimulate the immune response, small numbers of parasites are necessary to be presented in the mammalian host. Similar to natural course of infection, strategy using live vaccine is more attractive when compared to other approaches. Live vaccines present the whole spectrum of antigens to the host immune system in the absence of any adjuvant. Leishmanization was the first effort for live vaccination and currently used in a few countries against cutaneous leishmaniasis, in spite of their obstacle and safety. Then, live attenuated vaccines developed with similar promotion of creating long-term immunity in the host with lower side effect. Different examples of attenuated strains are generated through long-term in vitro culturing, culturing under drug pressure, temperature sensitivity, and chemical mutagenesis, but none is safe enough and their revision to virulent form is possible. Attenuation through genetic manipulation and disruption of virulence factors or essential enzymes for intracellular survival are among other approaches that are intensively under study. Other designs to develop live vaccines for visceral form of leishmaniasis are utilization of live avirulent microorganisms such as Lactococcus lactis, Salmonella enterica, and Leishmania tarentolae called as vectored vaccine. Apparently, these vaccines are intrinsically safer and can harbor the candidate antigens in their genome through different genetic manipulation and create more potential to control Leishmania parasite as an intracellular pathogen.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 93 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 2%
India 1 1%
Brazil 1 1%
Unknown 89 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 20 22%
Student > Ph. D. Student 14 15%
Researcher 11 12%
Student > Bachelor 8 9%
Student > Doctoral Student 8 9%
Other 13 14%
Unknown 19 20%
Readers by discipline Count As %
Agricultural and Biological Sciences 21 23%
Biochemistry, Genetics and Molecular Biology 17 18%
Immunology and Microbiology 13 14%
Medicine and Dentistry 8 9%
Social Sciences 3 3%
Other 10 11%
Unknown 21 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 March 2014.
All research outputs
#22,905,350
of 25,540,105 outputs
Outputs from Frontiers in immunology
#27,745
of 31,935 outputs
Outputs of similar age
#208,658
of 239,676 outputs
Outputs of similar age from Frontiers in immunology
#96
of 117 outputs
Altmetric has tracked 25,540,105 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 31,935 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 239,676 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 117 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.